Barrow Hanley Mewhinney & Strauss LLC Pfizer Inc Transaction History

Barrow Hanley Mewhinney & Strauss LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $191 Million - $248 Million	-5,893,513 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $547 Million - $614 Million	-14,796,549 Reduced 71.52%	5,893,513 $255 Million
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $391 Million - $430 Million	-10,428,233 Reduced 33.51%	20,690,062 $879 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $151 Million - $172 Million	-3,919,376 Reduced 11.19%	31,118,295 $1.36 Billion
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $145 Million - $176 Million	-4,203,974 Reduced 10.71%	35,037,671 $1.54 Billion
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $63.1 Million - $67.3 Million	-1,913,518 Reduced 4.65%	39,241,645 $1.42 Billion
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $33.7 Million - $39.1 Million	-1,056,865 Reduced 2.5%	41,155,163 $1.46 Billion
Q4 2017 Feb 09, 2018	SELL	$33.26 - $35.29 $74.1 Million - $78.6 Million	-2,226,600 Reduced 5.01%	42,212,028 $1.53 Billion
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $1.38 Billion - $1.52 Billion	44,438,628	44,438,628 $1.59 Billion

3,256

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Barrow Hanley Mewhinney & Strauss LLC, based on Form 13F filings with the SEC.

Stay updated on Barrow Hanley Mewhinney & Strauss LLC with notifications on news.